Anisha A D'Souza (Anisha D'Souza)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Chronic Rhinosinusitis

Top Venues

Molecular pharmaceutics

Nanomedicine (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics (2023)
Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics 20 (3) (2023)
Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics 20 (3) (2023)
Andy Jian Kai Chua, Valentina Di Francesco, Di Huang, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Nanotechnology-enabled topical delivery of therapeutics in chronic rhinosinusitis. Nanomedicine (London, England) (2023)
Maie S Taha, Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Topical Administration of Verapamil in Poly(ethylene glycol)-Modified Liposomes for Enhanced Sinonasal Tissue Residence in Chronic Rhinosinusitis: Ex Vivo and In Vivo Evaluations. Molecular pharmaceutics 20 (3) (2023)
Shallu Kutlehria, Anisha A D'Souza, Benjamin S Bleier, Mansoor M Amiji
Role of 3D Printing in the Development of Biodegradable Implants for Central Nervous System Drug Delivery. Molecular pharmaceutics 19 (12) (2022)
Anisha A D'Souza, Shallu Kutlehria, Di Huang, Benjamin S Bleier, Mansoor M Amiji
Nasal delivery of nanotherapeutics for CNS diseases: challenges and opportunities. Nanomedicine (London, England) (2021)